Bibliografía del artículo
1. Bydlowski SP, Debes AA, Maselli LMF, Janz FL. Características biológicas das células-tronco mesenquimais. Rev Bras Hematol Hemoter 31(suppl 1):25-35, 2009.
2. Miura M, Gronthos S, Zhao M, Fisher LW, Robey PG, Shi S. SHED: Stem cells from human exfoliated deciduous teeth. Proc Natl Acad Sci USA 100(10):5807-12, 2003.
3. Javazon EH, Beggs KJ, Flake AW. Mesenchymal stem cells: paradoxes of passaging. Exp Hematol 32(5):414-25, 2004.
4. Krampera M, Pasini A, Pizzolo G, Cosmi L, Romagnani S, Annunziato F. Regenerative and immunomodulatory potential of mesenchymal stem cells. Curr Opi Pharmacol 6(4):435-41, 2006.
5. Krampera M, Marconi S, Pasini A e col. Induction of neural-like differentiation in human mesenchymal stem cells derived from bone marrow, fat, spleen and thymus. Bone 40(2):382-90, 2007.
6. Le Blanc K, Rasmusson I, Sundberg B e col. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363(12):1439-41, 2004.
7. Pittenger MF, Martin BJ. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 95(1):9-20, 2004.
8. Da Silva Meirelles L, Caplan AI, Nardi NB. In search of the in vivo identity of mesenchymal stem cells. Stem Cells 26(9):2287-99, 2008.
9. Bobis S, Jarocha D, Majka M. Mesenchymal stem cells: characteristics and clinical applications. Folia Histochem Cytobiol 44(4):215-30, 2006.
10. Gronthos S, Mankani M, Brahim J, Robey G, Shi S. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci USA 97(25):13625-30, 2000.
11. Roufosse CA, Direkze NC, Otto WR, Wrigth NA. Circulating mesenchymal stem cells. Int J Biochem Cell Biol 36(4):585-97, 2004.
12. Nadig RR. Stem Cell therapy - Hype or hope? A review. J Conserv Dent 12(4):131-8, 2009.
13. Cai J, Weiss ML, Rao MS. In search of "stemness". Exp Hematol 32(7):585-98, 2004.
14. Shi S, Gronthos S. Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. J Bone Miner Res 18(4):696-704, 2003.
15. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol 8(9):726-36, 2008.
16. Izadpanah R, Trygg C, Patel B e col. Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue. J Cell Biochem 99(5):1285-97, 2006.
17. Govindasamy V, Ronald VS, Totey S e col. Micromanipulation of culture niche permits long-term expansion of dental pulp stem cells - and economic and commercial angle. In Vitro Cell Dev Biol Anim 46(9):764-73, 2010.
18. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105(4):1815-22, 2005.
19. Conget PA, Minguell JJ. Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol 181(1):67-73, 1999.
20. Anjos-Afonso F, Bonnet D. Nonhematopoietic/endothelial SSEA-1+ cells define the most primitive progenitors in the adult murine bone marrow mesenchymal compartment. Blood 109(1):1298-306, 2007.
21. Gang EJ, Bosnakovski D, Figueiredo CA, Visser JW, Perlingeiro RCR. SSEA-4 identifies mesenchymal stem cells from bone marrow. Blood 109(15):1743-51, 2007.
22. Tse WT, Pendleton JD, Egalka MC, Guinan EC. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75(3):389-97, 2003.
23. DiNicola M, Carlo-Stella C, Magni M e col. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99(10):3838-43, 2002.
24. Le Blanc K. Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy 5(6):485-9, 2003.
25. Zhang W, Ge W, Li C e col. Effects of mesenchymal stem cells on differentiation, maturation and function of human monocyte-derived dendritic cells. Stem Cells Dev 13(3):263-71, 2004.
26. Glennie S, Soeiro I, Dyson PJ, Lam EW, Dazzi F. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 105(7):2821-7, 2005.
27. Klyushnenkova E, Mosca JD, Zernetkina V e col. T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. J Biomed Sci 12(1):47-57, 2005.
28. Corcione A, Benvenuto F, Ferretti E e col. Human mesenchymal stem cells modulate B-cell functions. Blood 107(1):367-72, 2006.
29. Spaggiari GM, Capobianco A, Abdelrazik H, Becchetti F, Mingari MC, Moretta L. Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood 111(3):1327-33, 2008.
30. Spaggiari GM, Abdelrazik H, Becchetti F, Moretta L. MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. Blood 113(26):6576-83, 2009.
31. Asari S, Itakura S, Ferreri K e col. Mesenchymal stem cells suppress B-cell terminal differentiation. Exp Hematol 37(5):604-15, 2009.
32. Tolar J, Hippen KL, Blazar BR. Immune regulatory cells in umbilical cord blood: T regulatory cells and mesenchymal stromal cells. Br J Haematol 147(2):200-6, 2009.
33. Ryan JM, Barry FP, Murphy JM, Mahon BP. Mesenchymal stem cells avoid allogeneic rejection. J Inflamm (Lond) 2:8, 2005.
34. Le Blanc K, Tammik C, Rosendahl, Zetterberg, Ringén O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 31(10):890-6, 2003.
35. Jiang XX, Zhang Y, Liu B, Zhang SX, Wu Y, Yu XD, Mao N. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 105(10):4120-6, 2005.
36. Abbas AK, Lichtman AH, Pillai S. Cellular and molecular immunology. 6th ed. Philadelphia: Elsevier; 2007. 566 pp.
37. Nauta AJ, Kruisselbrink AB, Lurvink E, Willemze R, Fibbe WE. Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells. J Immunol 177(4):2080-7, 2006.
38. Krampera M, Glennie S, Dyson J, Scott D, Laylor R, Simpson E, Dazzi F. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 101(9):3722-9, 2003.
39. Le Blanc K, Tammik L, Sundberg B, Haynesworth SE, Ringdén O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 57(1):11-20, 2003.
40. Djouad F, Plence P, Bony C e col. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 102(10):3837-44, 2003.
41. Bartholomew A, Sturgeon C, Siatskas M e col. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30(1):42-8, 2002.
42. Rasmusson I, Ringdén O, Sundberg B, Le Blanc K. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation 76(8):1208-13, 2003.
43. Augello A, Tasso R, Negrini SM e col. Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. Eur J Immunol 35(5):1482-90, 2005.
44. Comoli P, Ginevri, Maccario R e col. Human mesenchymal stem cells inhibit antibody production induced in vitro by allostimulation. Nephrol Dial Transplant 23(4):1196-202, 2008.
45. Meisel R, Zibert A, Laryea M, Göbel U, Däubener W, Dillo D. Human bone marrow stromal cells inhibit allogeneic T-cells responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 103(12):4619-21, 2004.
46. Sato K, Ozaki, Oh I e col. Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood 109(1):228-34, 2007.
47. Patel SA, Meyer JR, Greco SJ, Corcoran KE, Bryan M, Rameshwar P. Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta. J Immunol 184(10):5885-94, 2010.
48. Hunt JS, Petroff MG, Morales P, Sedlmayr P, Geraghty DE, Ober C. HLA-G in reproduction: studies on the maternal-fetal interface. Hum Immunol 61(11):1113-7, 2000.
49. Selmani Z, Naji A, Zidi I e col. Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells. Stem Cells 26(1):212-22, 2008.
50. Bassi EJ, Aita CAM, Câmara NOS. Immune regulatory properties of multipotent mesenchymal stromal cells: Where do we stand? World J Stem Cells 3(1):1-8, 2011.
51. Le Blanc K, Frassoni F, Ball L e col. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 371(9624):1579-86, 2008.
52. De Bari C, Dell' Accio F, Vandenabeele F, Vermeesch JR, Raymackers JM, Luyten FP. Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane. J Cell Biol 160(6):909-18, 2003.
53. Seo BM, Sonoyama W, Yamaza T e col. SHED repair critical-size calvarial defects in mice. Oral Dis 14(5):428-34, 2008.
54. Rios D, Vieira ALF, Tenuda LMA, Machado MAAM. Osteogenesis imperfecta and dentinogenesis imperfecta: associated disorders. Quintessence Int 36(9):695-701, 2005.
55. Horwitz EM, Prockop DJ, Gordon PL e col. Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood 97(5):1227-31, 2001.
56. Horwitz EM, Gordon PL, Koo WKK e col. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci USA 99(13):8932-7, 2002. 57. González MA, Gonzalez-Rey E, Rico L, Büscher D, Delgado M. Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. Arthritis Rheum 60(4):1006-19, 2009.
58. Fiorina P, Jurewicz M, Augello A e col. Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes. J Immunol 183(2):993-1004, 2009.